GFAP and Alzheimer disease: In MCI participants, plasma GFAP detected AD pathology and predicted conversion to AD dementia (AROC = 0.84); in the latter case, adding APOE-ε4 or age to the model did not significantly improve the accuracy of the diagnosis [71].